Guatemala Specific Pollen Allergies Market, By Drug Type (Antihistamines, Decongestants, Corticosteroids, Anticholinergics and Others), Diagnostic Test (In Vivo Test and In Vitro Test), Product (Instruments, Reagents and Kits, and others), End-User (Hospitals, Diagnostics Laboratories, Academic and Research Institutes, and Others), Distribution Channel (Direct Tender and Retail Sales) – Industry Trends and Forecast to 2030.
Guatemala Specific Pollen Allergies Market Analysis and Size
The high prevalence of pollen allergic response, increasing approval of new drug products in Guatemala with different advance therapies combating allergies are driving the market growth. Pollen aeroallergens can act as opportunity for the market and propel the market. The Impact on paediatric population depends on environmental conditions, changes in the use of soil, different pollen seasons, and annual data for allergists in terms of planning the treatment, will drive the specific pollen allergies market growth.
Data Bridge Market Research analyses that the Guatemala specific pollen allergies market which was USD 393.69 million in 2022, and is expected to USD 589.51 million by 2030, and is expected to undergo a CAGR of 5.4% during the forecast period. This indicates that the market value. “Hospitals” dominates the end-user segment of the specific pollen allergies market owing to increase in demand for products in hospitals. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Guatemala Specific Pollen Allergies Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Drug Type (Antihistamines, Decongestants, Corticosteroids, Anticholinergics and Others), Diagnostic Test (In Vivo Test and In Vitro Test), Product (Instruments, Reagents and Kits, and others), End-User (Hospitals, Diagnostics Laboratories, Academic and Research Institutes, and Others), Distribution Channel (Direct Tender and Retail Sales)
|
|
Countries Covered
|
Guatemala
|
|
Market Players Covered
|
Siemens Healthcare GmbH (Germany), Sanofi (France), bioMérieux SA (France), GlaxoSmithKline plc. (U.K.), Minaris Medical America, Inc. (U.S.), Quest Diagnostics Incorporated (U.S.), Circassia (U.K.), Alcon Inc. (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Johnson & Johnson SA de CV (Mexico), Lincoln Diagnostics, Inc. (U.S.), EUROIMMUN Medizinische Labordiagnostika AG (Germany), Bayer Pharmaceuticals (U.S.), Prestige Consumer Healthcare Inc. (U.S.), CINFA LABORATORIES (Spain), Perrigo Company plc. (Ireland) among others.
|
|
Market Opportunities
|
|
Market Definition
Allergic diseases are the immunological response of the body to a particulate matter when it invades the body. These include hay fever, food allergies, atopic dermatitis, allergic asthma, and anaphylaxis. Symptoms may include red eyes, an itchy rash, sneezing, a runny nose, shortness of breath, or swelling. These pollens (typically weed pollens) are easily found in the atmosphere in the spring season as well as grass pollens in the summer. Most of the pollen that causes allergic reactions comes from trees, grasses, and weeds. These plants make small, light, and dry pollen grains that travel by air. These are easily found everywhere. Since, it is difficult to completely avoid allergens and therefore, it is crucial to accurately identify the causative antigen for rapid diagnosis and prompt initiation of treatment of allergen immunotherapy. Pollen counts are generally taken with an air-sampling device. The prevalence of allergic diseases is increasing, which requires an integrated method for diagnosis, treatment and greater awareness among patients.
Guatemala Specific Pollen Allergies Market Dynamics
Drivers
- Increasing Prevalence of Allergic Disorder
The hypersensitive response of the immune system of an allergic individual to a substance is known as allergic reaction. When an allergen enters the body, it causes the body's immune system to develop an allergic reaction. This reaction can occur when the immune system attacks a normally harmless substance. This can happen in any age, but more frequent in younger age due to the proper functioning of immune response.
Different individuals can be allergic to various allergens, such as pollens allergies among others, which are some of the common allergic reactions. The prevalence of allergic diseases is increasing, which requires an integrated method for diagnosis, treatment and greater awareness among patients. A vast population is suffering from allergic diseases that have generated a significant burden. Rising cases of allergies are expected to increase the demand for treatment, leading to the high growth of the market over the forecast period.
- Impact of Pollen Allergies on Pediatric Population
Pollen grains are commonly present in the atmosphere that cause various allergic diseases in North America. Pollen aeroallergens can act as opportunity for the market and propel the market in Mexico. The Impact on paediatric population depends on environmental conditions, changes in the use of soil, different pollen seasons, and annual data for allergists in terms of planning the treatment. The increase in forecasted pollen season longer than usual. The growth of the pollen market can be attributed to the increase in the tree pollen season in the country that elicits allergic reactions such as hay fever and rhinitis in the population which is anticipated to drive the market. Pollen in the atmosphere of Mexico City and its impact on the health of the paediatric population.
Hence, prevalence of pollen-induced allergic disease has been increasing with severe symptoms that can be one of the most common health issues affecting adults. Children are the largest age group affected. Coexistence of allergic diseases was found in 19.9%.This is expected to be one of the factors that act as a driver for the Guatemala specific pollen allergies market growth in the forecast period.
Opportunity
- Increase in the Environmental Pollution
Common air pollutants, such as ozone, sulphur dioxide, and nitrogen dioxide probably act more as irritants than as promoters of sensitization. These pollutants have been shown to be hazardous to adults and children with asthma. Recent studies suggest that prematurely born children are more sensitive to the respiratory effects of outdoor pollution.
Thus, pollution and allergies go hand-in-hand, worsening air and water pollution enables various heavy metals and non-metals an opportunity to come in close contact with skin and respiratory system thus causing allergies. This is increasing the demand for allergy medications.
The increasing air pollution along with water population is expected to increase the prevalence of respiratory and skin allergies, which is expected to increase the demand for the product used for allergy hence it is considered as opportunity for the market.
Restraint/Challenge
- Side Effects Associated with the Use of Drugs
Sometimes drugs have some kind of side effects or adverse effects among the population. The treatment of allergic response is a multi-drugs therapy, which has a greater chance of compatibility issue, which can cause the condition to get worse. Corticosteroids are known to lower the resistance to infection, which can make it harder to treat. It induced osteoporosis, steroids induced myopathy, and osteonecrosis are some of the disorders that are seen among those that use corticosteroids. Systemic administration of these drugs are known to increase the fasting blood glucose level, which make it vulnerable for the diabetic patients to use these therapies during allergic reaction, hence limiting the market growth.
Drowsiness, headache, dry mouth, throat, and/or nose, stomach pain, nausea, mucus thickening, and increased appetite/weight gain are some of the side effects induced in the patient taking anti-histaminic. Among all, the drug induced diseases are mostly seen among those that use corticosteroids therapy for longer period of time. These side effects of the drug is expected to limit the use of drugs hence act as restraint for the growth of the Guatemala specific pollen allergies market in the forecast period.
This specific pollen allergies market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the specific pollen allergies market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In July 2021, Prestige Consumer Healthcare announced that the company has completed the previously announced acquisition of TheraTears and other over-the-counter consumer brands. This is expected to increase the company’s manufacturing capacity in the U.S. and help in revenue generation
- In September 2021, EUROIMMUN Medizinische Labordiagnostika AG and Immunodiagnostic Systems (IDS) partnership to cooperate in the fields of research and development, production as well as distribution, and this will help to grow the business and generate revenue
Guatemala Specific Pollen Allergies Market Scope
Guatemala specific pollen allergies market is segmented on the basis of drug type, diagnostic test, product, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Drug Type
- Antihistamines
- Decongestants
- Corticosteroids
- Anticholinergics
- Others
Diagnostic Test
- In Vivo Test
- In Vitro Test
Product
- Instruments
- Reagents and Kits
- others
End-User
- Hospitals
- Diagnostics Laboratories
- Academic and Research Institutes
- Others
Distribution Channel
- Direct Tender
- Retail Sales
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The Guatemala specific pollen allergies market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for healthcare analytics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the healthcare analytics market. The data is available for historic period 2015 to 2020.
Competitive Landscape and Specific Pollen Allergies Market Share Analysis
The Guatemala specific pollen allergies market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company's focus related to Guatemala specific pollen allergies market.
Some of the major players operating in the Guatemala specific pollen allergies market are:
- Siemens Healthcare GmbH (Germany)
- Sanofi (France)
- bioMérieux SA (France)
- GlaxoSmithKline plc. (U.K.)
- Minaris Medical America, Inc. (U.S.)
- Quest Diagnostics Incorporated (U.S.)
- Circassia (U.K.)
- Alcon Inc. (Switzerland)
- Thermo Fisher Scientific Inc. (U.S.)
- Johnson & Johnson SA de CV (Mexico)
- Lincoln Diagnostics, Inc. (U.S.)
- EUROIMMUN Medizinische Labordiagnostika AG (Germany)
- Bayer Pharmaceuticals (U.S.)
- Prestige Consumer Healthcare Inc. (U.S.)
- CINFA LABORATORIES (Spain)
- Perrigo Company plc. (Ireland)
SKU-